Select Publications
Alberts DS et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996;335(26):1950-5. Abstract
Armstrong DK et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354(1):34-43. Abstract
Burger RA et al. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic Oncology Group study. J Clin Oncol 2007;25(33):5165-71. Abstract
Cannistra SA et al. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. J Clin Oncol 2007;25(33):5180-6. Abstract
Duncan TJ et al. Vascular endothelial growth factor expression in ovarian cancer: A model for targeted use of novel therapies? Clin Cancer Res 2008;14(10):3030-5. Abstract
Hamilton CA et al. Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer. Gynecol Oncol 2008;[Epub ahead of print]. Abstract
Kaye SB. Bevacizumab for the treatment of epithelial ovarian cancer: Will this be its finest hour? J Clin Oncol 2007;25(33):5150-2. No abstract available
Markman M et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An Intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001;19(4):1001-7. Abstract
Spannuth WA et al. Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol 2008;5(4):194-204. Abstract
Table of Contents | Top of Page |
EDITOR
Neil Love, MD
INTERVIEWS
Tate Thigpen, MD
- Select publications
Ursula A Matulonis, MD
- Select publications
Robert A Burger, MD
- Select publications
Bradley J Monk, MD
- Select publications
Ovarian Cancer Update:
A CME Audio Series and Activity